BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ierardi E, Giorgio F, Losurdo G, Di Leo A, Principi M. How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography? World J Gastroenterol 2013; 19(45): 8168-8180 [PMID: 24363506 DOI: 10.3748/wjg.v19.i45.8168]
URL: https://www.wjgnet.com/1007-9327/full/v19/i45/8168.htm
Number Citing Articles
1
Ghadeer Turki Aloutaibi, Abdulrahman L. Al-Malki, Maha J. Balgoon, Saud A. Bahaidarah, Said Salama Moselhy. Rheumatic Heart Disease and Its Association with H. pylori InfectionJournal of Pure and Applied Microbiology 2021; 15(2): 580 doi: 10.22207/JPAM.15.2.42
2
Binjie Hu, Fuju Zhao, Shiwen Wang, Michal A Olszewski, Haipeng Bian, Yong Wu, Mimi Kong, Lingli Xu, Yingxin Miao, Yi Fang, Changqing Yang, Hu Zhao, Yanmei Zhang. A high-throughput multiplex genetic detection system for Helicobacter pylori identification, virulence and resistance analysisFuture Microbiology 2016; 11(10): 1261 doi: 10.2217/fmb-2016-0023
3
Lynne V McFarland, Ying Huang, Lin Wang, Peter Malfertheiner. Systematic review and meta-analysis: Multi-strain probiotics as adjunct therapy forHelicobacter pylorieradication and prevention of adverse eventsUnited European Gastroenterology Journal 2016; 4(4): 546 doi: 10.1177/2050640615617358
4
Enzo Ierardi, Giuseppe Losurdo, Alessia Mileti, Rosa Paolillo, Floriana Giorgio, Mariabeatrice Principi, Alfredo Di Leo. The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic ScienceAntibiotics 2020; 9(6): 293 doi: 10.3390/antibiotics9060293
5
Ahmed Hossain, Saeem Arafat Hossain, Aneeka Nawar Fatema, Abrar Wahab, Mohammad Morshad Alam, Md. Nazrul Islam, Mohammad Zakir Hossain, Gias U. Ahsan. Age and gender-specific antibiotic resistance patterns among Bangladeshi patients with urinary tract infection caused by Escherichia coliHeliyon 2020; 6(6): e04161 doi: 10.1016/j.heliyon.2020.e04161
6
Sin&eacute;ad M Smith, Colm O&rsquo;Morain, Deirdre McNamara. Antimicrobial susceptibility testing for <italic>Helicobacter pylori</italic> in times of increasing antibiotic resistanceWorld Journal of Gastroenterology 2014; 20(29): 9912-9921 doi: 10.3748/wjg.v20.i29.9912
7
Ali Baradaran Moghaddam, Nour Amirmozafari, Shahla Mansouri, Nastaran Farzi, Naser Ebrahimi-Daryani, Masoud Alebouyeh, Mohammad Reza Zali. Nitazoxanide and Doxycycline Sensitivity Among Metronidazole Resistant Helicobacter pylori Isolates from Patients with GastritisArchives of Clinical Infectious Diseases 2018; 13(1) doi: 10.5812/archcid.66693
8
Priscila Baptistella Yazbek, Ariane Biolcati Trindade, Chung Man Chin, Jean Leandro dos Santos. Challenges to the Treatment and New Perspectives for the Eradication of Helicobacter pyloriDigestive Diseases and Sciences 2015; 60(10): 2901 doi: 10.1007/s10620-015-3712-y
9
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic MutationsPLOS ONE 2016; 11(12): e0166199 doi: 10.1371/journal.pone.0166199
10
Aldona Bińkowska, Monika Maria Biernat, Łukasz Łaczmański, Grażyna Gościniak. Molecular Patterns of Resistance Among Helicobacter pylori Strains in South-Western PolandFrontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.03154
11
Nastaran Farzi, Abbas Yadegar, Amir Sadeghi, Hamid Asadzadeh Aghdaei, Sinéad Marian Smith, Josette Raymond, Hidekazu Suzuki, Mohammad Reza Zali. High Prevalence of Antibiotic Resistance in Iranian Helicobacter pylori Isolates: Importance of Functional and Mutational Analysis of Resistance Genes and Virulence GenotypingJournal of Clinical Medicine 2019; 8(11): 2004 doi: 10.3390/jcm8112004
12
Abu Iftiaf Md Salah Ud-Din, Anna Roujeinikova. Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeuticsCellular and Molecular Life Sciences 2018; 75(7): 1163 doi: 10.1007/s00018-017-2696-5
13
Sukdong Lee, Gregory T. Sneed, Jamie N. Brown. Treatment of Helicobacter pylori with nitazoxanide-containing regimens: a systematic reviewInfectious Diseases 2020; 52(6): 381 doi: 10.1080/23744235.2019.1708454
14
CA Chew, TF Lye, D Ang, TL Ang. The diagnosis and management of H. pylori infection in SingaporeSingapore Medical Journal 2017; 58(5): 234 doi: 10.11622/smedj.2017037
15
Muhammad Miftahussurur, Yoshio Yamaoka. Helicobacter pylori Research2016; : 519 doi: 10.1007/978-4-431-55936-8_23
16
Breno Bittencourt de Brito, Filipe Antônio França da Silva, Aline Silva Soares, Vinícius Afonso Pereira, Maria Luísa Cordeiro Santos, Mariana Miranda Sampaio, Pedro Henrique Moreira Neves, Fabrício Freire de Melo. Pathogenesis and clinical management of <i>Helicobacter pylori</i> gastric infectionWorld Journal of Gastroenterology 2019; 25(37): 5578-5589 doi: 10.3748/wjg.v25.i37.5578
17
Enzo Ierardi, Floriana Giorgio, Giuseppe Losurdo, Claudia Sorrentino, Mariabeatrice Principi, Alfredo Di Leo. Detection of Helicobacter pylori DNA sequences in gastric biopsy samples to refine the diagnosis and therapy Journal of Medical Microbiology 2015; 64(7): 788 doi: 10.1099/jmm.0.000075
18
G. Losurdo, G. Leandro, M. Principi, F. Giorgio, L. Montenegro, C. Sorrentino, E. Ierardi, A. Di Leo. Sequential vs. prolonged 14-day triple therapy forHelicobacter pylorieradication: the meta-analysis may be influenced by ‘geographical weighting’International Journal of Clinical Practice 2015; 69(10): 1112 doi: 10.1111/ijcp.12687
19
Muhammad Miftahussurur, Pradeep Krishna Shrestha, Phawinee Subsomwong, Rabi Prakash Sharma, Yoshio Yamaoka. Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in NepalBMC Microbiology 2016; 16(1) doi: 10.1186/s12866-016-0873-6
20
Jun-Won Chung, Jae Pil Han, Kyoung Oh Kim, Su Young Kim, Su Jin Hong, Tae Ho Kim, Chang Whan Kim, Joon Sung Kim, Byung-Wook Kim, Byoung Wook Bang, Hyung Gil Kim, Sung-Cheol Yun. Ten-day empirical sequential or concomitant therapy is more effective than triple therapy for Helicobacter pylori eradication: A multicenter, prospective studyDigestive and Liver Disease 2016; 48(8): 888 doi: 10.1016/j.dld.2016.05.005
21
Giuseppe Losurdo, Ilaria Lacavalla, Francesco Russo, Giuseppe Riezzo, Irene Vita Brescia, Maria Rendina, Enzo Ierardi, Alfredo Di Leo. Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern ItalyAntibiotics 2022; 11(1): 78 doi: 10.3390/antibiotics11010078
22
R. Ntagirabiri, S. Harerimana, F. Makuraza, E. Ndirahisha, H. Kaze, A. Moibeni. Helicobacter pylori au Burundi : première évaluation de la prévalence en endoscopie et de l’éradicationJournal Africain d'Hépato-Gastroentérologie 2014; 8(4): 217 doi: 10.1007/s12157-014-0567-3
23
I-Ting Wu, Seng-Kee Chuah, Chen-Hsiang Lee, Chih-Ming Liang, Lung-Sheng Lu, Yuan-Hung Kuo, Yi-Hao Yen, Ming-Luen Hu, Yeh-Pin Chou, Shih-Cheng Yang, Chung-Mou Kuo, Chung-Huang Kuo, Chun-Chih Chien, Yu-Shao Chiang, Shue-Shian Chiou, Tsung-Hui Hu, Wei-Chen Tai. Five-year sequential changes in secondary antibiotic resistance of <italic>Helicobacter pylori</italic> in TaiwanWorld Journal of Gastroenterology 2015; 21(37): 10669-10674 doi: 10.3748/wjg.v21.i37.10669
24
Elvire Berthenet, Koji Yahara, Kaisa Thorell, Ben Pascoe, Guillaume Meric, Jane M. Mikhail, Lars Engstrand, Helena Enroth, Alain Burette, Francis Megraud, Christine Varon, John C Atherton, Sinead Smith, Thomas S. Wilkinson, Matthew D. Hitchings, Daniel Falush, Samuel K. Sheppard. A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer riskBMC Biology 2018; 16(1) doi: 10.1186/s12915-018-0550-3
25
Traci L Testerman, James Morris. Beyond the stomach: An updated view of <italic>Helicobacter pylori</italic> pathogenesis, diagnosis, and treatmentWorld Journal of Gastroenterology 2014; 20(36): 12781-12808 doi: 10.3748/wjg.v20.i36.12781
26
Seng-Kee Chuah, Wei-Chen Tai, Chen-Hsiang Lee, Chih-Ming Liang, Tsung-Hui Hu. Quinolone-Containing Therapies in the Eradication ofHelicobacter pyloriBioMed Research International 2014; 2014: 1 doi: 10.1155/2014/151543
27
David Y Graham, Ruben Hernaez, Theodore Rokkas. Cross-roads for meta-analysis and network meta-analysis of H. pylori therapyGut 2022; 71(3): 643 doi: 10.1136/gutjnl-2021-326170
28
Margarita Camorlinga-Ponce, Alejandro Gómez-Delgado, Emmanuel Aguilar-Zamora, Roberto C. Torres, Silvia Giono-Cerezo, Antonio Escobar-Ogaz, Javier Torres. Phenotypic and Genotypic Antibiotic Resistance Patterns in Helicobacter pylori Strains From Ethnically Diverse Population in MéxicoFrontiers in Cellular and Infection Microbiology 2021; 10 doi: 10.3389/fcimb.2020.539115
29
Muhammad Miftahussurur, Yoshio Yamaoka. Appropriate First-Line Regimens to Combat Helicobacter pylori Antibiotic Resistance: An Asian PerspectiveMolecules 2015; 20(4): 6068 doi: 10.3390/molecules20046068
30
Giuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori Antibiotic Resistance: Stewardship, Tailored Therapies, and Future PerspectivesGastroenterology 2021; 161(3): 1071 doi: 10.1053/j.gastro.2021.05.045
31
Enrique Rodríguez de Santiago, Carlos Martín de Argila de Prados, Hector Miguel Marcos Prieto, Miguel Ãngel Jorge Turrión, Eva Barreiro Alonso, Alvaro Flores de Miguel, Cristobal de la Coba Ortiz, Carlos Rodríguez Escaja, Gustavo Pérez Álvarez, Carlos Ferre Aracil, Lara Aguilera Castro, Ana García García de Paredes, Antonio Rodríguez Pérez, Agustin Albillos Martínez. Limited effectiveness with a 10-day bismuth-containing quadruple therapy (Pylera® ) in third-line recue treatment for Helicobacter pylori infection. A real-life multicenter studyHelicobacter 2017; 22(5): e12423 doi: 10.1111/hel.12423
32
Makan Pourmasoumi, Ameneh Najafgholizadeh, Amir Hadi, Fariborz Mansour-Ghanaei, Farahnaz Joukar. The effect of synbiotics in improving Helicobacter pylori eradication: A systematic review and meta-analysisComplementary Therapies in Medicine 2019; 43: 36 doi: 10.1016/j.ctim.2019.01.005
33
Maliheh Safavi, Reyhaneh Sabourian, Alireza Foroumadi. Treatment of <i>Helicobacter pylori</i> infection: Current and future insightsWorld Journal of Clinical Cases 2016; 4(1): 5-19 doi: 10.12998/wjcc.v4.i1.5
34
Giuseppe Losurdo, Andrea Iannone, Floriana Giorgio, Mariabeatrice Principi, Alfredo Di Leo, Enzo Ierardi. Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen forHelicobacter pylorieradication: how should rifabutin be managed in rescue regimens?United European Gastroenterology Journal 2016; 4(3): 474 doi: 10.1177/2050640615623697
35
Tiing Leong Ang, Kwong Ming Fock, Daphne Ang, Andrew Boon Eu Kwek, Eng Kiong Teo, Subbiah Dhamodaran. The Changing Profile ofHelicobacter pyloriAntibiotic Resistance in Singapore: A 15-Year StudyHelicobacter 2016; 21(4): 261 doi: 10.1111/hel.12291
36
Enzo Ierardi, Giuseppe Losurdo, Rosa Federica La Fortezza, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo. Optimizing proton pump inhibitors in <i>Helicobacter pylori</i> treatment: Old and new tricks to improve effectivenessWorld Journal of Gastroenterology 2019; 25(34): 5097-5104 doi: 10.3748/wjg.v25.i34.5097
37
Mijung Lee, Jin-Young Chung, Ka Yeun Kim, Wooseok Im, Manho Kim. Two-weeks repeated-dose oral toxicity study of Pediococcus acidilactici J9 in a mice modelBMC Microbiology 2020; 20(1) doi: 10.1186/s12866-020-02055-4
38
Ali Bahadori, Tülin Güven Gökmen, Fatih Köksal, Gökhan Tumgor, Mehmet Agin, Ali Sadighi, Mojtaba Ziaee, Leila Rahbarnia. High prevalence of clarithromycin resistant Helicobacter pylori in Turkish children with gastric disordersGene Reports 2021; 24: 101275 doi: 10.1016/j.genrep.2021.101275
39
Enzo Ierardi, Floriana Giorgio, Andrea Iannone, Giuseppe Losurdo, Mariabeatrice Principi, Michele Barone, Antonio Pisani, Alfredo Di Leo. Noninvasive molecular analysis of <i>Helicobacter pylori</i>: Is it time for tailored first-line therapy?World Journal of Gastroenterology 2017; 23(14): 2453-2458 doi: 10.3748/wjg.v23.i14.2453
40
Su Young Kim, Duck Joo Choi, Jun-Won Chung. Antibiotic treatment for <italic>Helicobacter pylori</italic>: Is the end coming?World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 183-198 doi: 10.4292/wjgpt.v6.i4.183
41
Daniel Pohl, Peter M Keller, Valentine Bordier, Karoline Wagner. Review of current diagnostic methods and advances in <i>Helicobacter pylori</i> diagnostics in the era of next generation sequencingWorld Journal of Gastroenterology 2019; 25(32): 4629-4660 doi: 10.3748/wjg.v25.i32.4629
42
Jin-Eung Kim, Min-Soo Kim, Yeo-Sang Yoon, Myung-Jun Chung, Do-Young Yum. Use of selected lactic acid bacteria in the eradication of Helicobacter pylori infectionJournal of Microbiology 2014; 52(11): 955 doi: 10.1007/s12275-014-4355-y
43
Kiwon Shin, Min-Jae Cho, Jung-Hwan Oh, Chul-Hyun Lim. Second-Line Bismuth-Containing Quadruple Therapy for Helicobacterpylori Infection: A 12-Year Study of Annual Eradication RatesJournal of Clinical Medicine 2021; 10(15): 3273 doi: 10.3390/jcm10153273
44
Giuseppe Losurdo, Rossella Cubisino, Michele Barone, Mariabeatrice Principi, Gioacchino Leandro, Enzo Ierardi, Alfredo Di Leo. Probiotic monotherapy and <i>Helicobacter pylori</i> eradication: A systematic review with pooled-data analysisWorld Journal of Gastroenterology 2018; 24(1): 139-149 doi: 10.3748/wjg.v24.i1.139
45
Hideki Mori, Hidekazu Suzuki. Reply to letter to the editor: “The dosage of rifabutin in H. pylori eradication regimen should be appropriately determined in each area of the world”United European Gastroenterology Journal 2016; 4(3): 476 doi: 10.1177/2050640616631477
46
Takahiro Uotani, Muhammad Miftahussurur, Yoshio Yamaoka. Effect of bacterial and host factors onHelicobacter pylorieradication therapyExpert Opinion on Therapeutic Targets 2015; 19(12): 1637 doi: 10.1517/14728222.2015.1073261
47
Amin Talebi Bezmin Abadi, Enzo Ierardi. Vonoprazan and Helicobacter pylori Treatment: A Lesson From Japan or a Limited Geographic Phenomenon?Frontiers in Pharmacology 2019; 10 doi: 10.3389/fphar.2019.00316
48
Jun-Won Chung, Su Young Kim, Hee Jung Park, Chang Su Chung, Hee Woo Lee, Sun Mi Lee, Inki Kim, Jhang Ho Pak, Gin Hyug Lee, Jin-Yong Jeong. In Vitro Activity of Diphenyleneiodonium toward Multidrug-Resistant Helicobacter pylori StrainsGut and Liver 2017; 11(5): 648 doi: 10.5009/gnl16503
49
Raffaele Licinio, Giuseppe Losurdo, Sonia Carparelli, Andrea Iannone, Floriana Giorgio, Michele Barone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori, liver cirrhosis, and portal hypertension: an updated appraisalImmunopharmacology and Immunotoxicology 2016; 38(6): 408 doi: 10.1080/08923973.2016.1247855
50
Sung Bum Kim, Si Hyung Lee, Kyeong Ok Kim, Byung Ik Jang, Tae Nyeun Kim. Ten-day Sequential TherapyversusBismuth Based Quadruple Therapy as Second Line Treatment forHelicobacter pyloriInfectionThe Korean Journal of Gastroenterology 2015; 66(5): 261 doi: 10.4166/kjg.2015.66.5.261
51
I. Thung, H. Aramin, V. Vavinskaya, S. Gupta, J. Y. Park, S. E. Crowe, M. A. Valasek. Review article: the global emergence ofHelicobacter pyloriantibiotic resistanceAlimentary Pharmacology & Therapeutics 2016; 43(4): 514 doi: 10.1111/apt.13497
52
Anil John, Saad Al Kaabi, Sanjay Doiphode, Prem Chandra, Manik Sharma, Ragesh Babu, Rafie Yacoub, Moutaz Derbala. Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?Indian Journal of Gastroenterology 2015; 34(5): 404 doi: 10.1007/s12664-015-0604-1
53
Floriana Giorgio, Enzo Ierardi, Claudia Sorrentino, Mariabeatrice Principi, Michele Barone, Giuseppe Losurdo, Andrea Iannone, Antonio Giangaspero, Rosa Monno, Alfredo Di Leo. Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysisScandinavian Journal of Gastroenterology 2016; 51(12): 1429 doi: 10.1080/00365521.2016.1216592
54
Skander Hathroubi, Stephanie L. Servetas, Ian Windham, D. Scott Merrell, Karen M. Ottemann. Helicobacter pylori Biofilm Formation and Its Potential Role in PathogenesisMicrobiology and Molecular Biology Reviews 2018; 82(2) doi: 10.1128/MMBR.00001-18
55
Heather S Laird-Fick, Shivani Saini, James Randolph Hillard. Gastric adenocarcinoma: the role ofHelicobacter pyloriin pathogenesis and prevention effortsPostgraduate Medical Journal 2016; 92(1090): 471 doi: 10.1136/postgradmedj-2016-133997
56
Paolo Ruggiero, Stefano Censini. Helicobacter pylori: A Brief History of a Still Lacking VaccineDiseases 2014; 2(2): 187 doi: 10.3390/diseases2020187
57
Shen-Shong Chang, Hsiao-Yun Hu. <italic>Helicobacter pylori</italic>: Effect of coexisting diseases and update on treatment regimensWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 127-136 doi: 10.4292/wjgpt.v6.i4.127
58
Fansen Meng, Hongjin Tao, Yan Mi, Tianyu Yang, Xuanping Wang, Yuyo Go, Yunjuan Lin, Gangshi Wang. Nanocluster-mediated photothermia improves eradication efficiency and antibiotic sensitivity of Helicobacter pyloriCancer Nanotechnology 2022; 13(1) doi: 10.1186/s12645-022-00121-2
59
Giuseppe Losurdo, Floriana Giorgio, Andrea Iannone, Mariabeatrice Principi, Michele Barone, Alfredo Di Leo, Enzo Ierardi. Role of concomitant therapy for <i>Helicobacter pylori</i> eradication: A technical noteWorld Journal of Gastroenterology 2016; 22(38): 8638-8640 doi: 10.3748/wjg.v22.i38.8638
60
Qin Ma, Hancong Li, Jing Liao, Zhaolun Cai, Bo Zhang. Tailored therapy for Helicobacter pylori eradication: A systematic review and meta-analysisFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.908202
61
Giuseppe Losurdo, Floriana Giorgio, Maria Pricci, Bruna Girardi, Francesco Russo, Giuseppe Riezzo, Manuela Martulli, Mariano Piazzolla, Francesco Cocomazzi, Francesco Abbruzzi, Elisabetta Parente, Rosa Paolillo, Alessia Mileti, Andrea Iannone, Mariabeatrice Principi, Enzo Ierardi, Alfredo Di Leo. Helicobacter pylori Primary and Secondary Genotypic Resistance to Clarithromycin and Levofloxacin Detection in Stools: A 4-Year Scenario in Southern ItalyAntibiotics 2020; 9(10): 723 doi: 10.3390/antibiotics9100723
62
Halil Rakici, Teslime Ayaz, Remzi Adnan Akdogan, Recep Bedir. Comparison of Levofloxacin- and Moxifloxacin-Based Triple Therapies with Standard Treatment in Eradication of Helicobacter Pylori as First-Line TherapyDigestion 2014; 90(4): 261 doi: 10.1159/000369788
63
Judit Alarcón-Millán, Gloria Fernández-Tilapa, Enoc Mariano Cortés-Malagón, Carlos Alberto Castañón-Sánchez, José De Sampedro-Reyes, Iván Cruz-del Carmen, Reyes Betancourt-Linares, Adolfo Román-Román. Clarithromycin resistance and prevalence of Helicobacter pylori virulent genotypes in patients from Southern México with chronic gastritisInfection, Genetics and Evolution 2016; 44: 190 doi: 10.1016/j.meegid.2016.06.044
64
Andrea Iannone, Floriana Giorgio, Francesco Russo, Giuseppe Riezzo, Bruna Girardi, Maria Pricci, Suetonia C Palmer, Michele Barone, Mariabeatrice Principi, Giovanni FM Strippoli, Alfredo Di Leo, Enzo Ierardi. New fecal test for non-invasive <i>Helicobacter pylori</i> detection: A diagnostic accuracy studyWorld Journal of Gastroenterology 2018; 24(27): 3021-3029 doi: 10.3748/wjg.v24.i27.3021
65
Hideki Mori, Hidekazu Suzuki, Juntaro Matsuzaki, Hitoshi Tsugawa, Seiichiro Fukuhara, Sawako Miyoshi, Kenro Hirata, Takashi Seino, Misako Matsushita, Tatsuhiro Masaoka, Takanori Kanai. Efficacy of 10-day Sitafloxacin-Containing Third-Line Rescue Therapies forHelicobacter pyloriStrains Containing thegyrAMutationHelicobacter 2016; 21(4): 286 doi: 10.1111/hel.12286
66
Jae Ho Choi, Young Joo Yang, Chang Seok Bang, Jae Jun Lee, Gwang Ho Baik. Current Status of the Third-LineHelicobacter pyloriEradicationGastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/6523653